Not Applicable.
The disclosure relates generally to controlled fluid transfer, and more specifically, to systems and methods for blood transfer from a syringe to a secondary container.
Certain fluid transfer processes, such as blood transfer within the context of phlebotomy, for example, can put users, such as healthcare or lab workers, at risk of unwanted blood or needle exposure. In particular, in certain healthcare settings, a healthcare worker may need to transfer blood from a syringe to another receptacle or secondary container. Unwanted blood exposure can occur during the transfer process of the blood to the secondary container, which may not be carried out in a closed transfer system.
The present disclosure provides systems and methods for shielded blood transfer. In one configuration, a fluid transfer shield is provided that facilitates transferring fluid from a first container to a secondary container. The fluid transfer shield can include a shield having an exterior and defining an interior space. A first port can extend from the exterior of the shield and can be configured to be fluidly coupled to the first container. A second port can extend opposite the first port and into the interior space of the shield so that the shield laterally surrounds the second port. The second port can be configured to be fluidly coupled to the secondary container. A passageway can extend between the first port and the second port to fluidly couple the first container and the secondary container when the first container is fluidly coupled to the first port and the secondary container is fluidly coupled to the second port.
Some configurations provide a fluid transfer shield that includes a second port having a relief path to allow air flow between a secondary container and the environment when the secondary container is secured to the second port.
Some configurations provide a fluid transfer shield that includes a relief path formed by a pair of planar faces on opposing sides of a second port. The pair of planar faces can be configured to form a channel between an exterior surface of the second port and an interior surface of a secondary container when the secondary container is secured to the second port.
Some configurations provide a fluid transfer shield that includes a flange extending radially from an exterior of a shield proximate to a base of the shield.
Some configurations provide a fluid transfer shield and first and second support ribs that extend from an exterior of a shield to a flange to rigidly support the flange.
Some configurations provide a fluid transfer shield having a perimeter of a fluid transfer shield, the perimeter including a shield and a flange adjacent to a base of the shield. The perimeter can form an oblong footprint.
Some configurations provide a fluid transfer shield that includes a second port. The second port can include an interior surface that defines a passageway and an exterior surface. The exterior surface can have a tapered geometry so that a distal end of the second port is narrower than a proximal end of the second port.
Some configurations provide a fluid transfer shield that includes a first port. The first port can include a female Luer lock connector. A first container can be configured as a syringe having a male Luer lock connector to fluidly couple the syringe to the first port via the female Luer lock connector.
Some configurations provide a fluid transfer shield with a second port. The second port can extend between approximately 7 millimeters and 11 millimeters into an interior space of a shield and the shield can define a body height that is between approximately 16 millimeters and 24 millimeters.
Some configurations provide a fluid transfer shield having an opening diameter of a shield between approximately 14 millimeters and 22 millimeters and an overall height of the fluid transfer shield between approximately 22 millimeters and 33 millimeters.
Configurations of the present disclosure provide a blood transfer shield for fluidly coupling a syringe and a secondary container. The blood transfer shield can include a shield, a passageway, and a first port. The shield can have a cylindrical body and a base that defines an opening at a first end of the cylindrical body. A passageway can extend through the cylindrical body of the shield. The passageway can be formed at a second end of the cylindrical body opposite the base. The first port can form a first end of the passageway. The first port can be configured to securely engage the syringe to fluidly couple the syringe to the passageway.
In some configurations, a blood transfer shield can include a second port that forms a second end of a passageway. The second port can be laterally surrounded by a shield.
In some configurations, a blood transfer shield can include a second port that defines an exterior surface opposite of a passageway. The exterior surface can be configured to be inserted into an opening of a secondary container to fluidly couple the secondary container with the passageway.
In some configurations, a blood transfer shield can include an exterior surface having a first pair of faces and a second pair of faces. The first pair of faces can be configured as curved surfaces that extend along a second port in an axial direction and the second pair of faces can be configured as flat surfaces that extend along the second port in the axial direction.
In some configurations, a blood transfer shield can include a second pair of faces that are configured to form an air relief channel with an opening of a secondary container when the secondary container is fluidly coupled with a passageway.
In some configurations, a blood transfer shield can include a flange extending radially from a cylindrical body of a shield adjacent to an opening. First and second buttresses can extend downward from a second end of the cylindrical body to the flange.
In some configurations, a blood transfer shield can include a first port and second port that are tapered so that a respective distal end is narrower than a respective proximal end of the first and second ports.
Some configurations of the present disclosure provide a method of transferring blood from a first container to a secondary container. The method can include drawing blood into the first container, fluidly coupling the first container to a first port of a blood transfer shield, the first port extending from an exterior surface of the blood transfer shield, fluidly coupling the secondary container to a second port of the blood transfer shield, the second port extending within an interior space defined by a lateral side wall of a shield of the blood transfer shield, and expelling blood from the first container into the second container via a passageway extending between the first port and the second port.
In some configurations, a method of transferring blood from a first container to a secondary container can include fluidly coupling the first container to the second container by twisting the first container relative to a blood transfer shield.
The disclosure will be better understood and features, aspects, and advantages other than those set forth above will become apparent when consideration is given to the following detailed description thereof. Such detailed description makes reference to the following drawings which may not be drawn to scale.
It is to be understood that the present disclosure is not limited in its application to the details of construction and the arrangement of components set forth in the following description or illustrated in the following drawings. The systems and methods described herein are capable of other configurations and of being practiced or of being carried out in various ways. Also, it is to be understood that the phraseology and terminology used herein is for the purpose of description and should not be regarded as limiting. The use of “including,” “comprising,” or “having” and variations thereof herein is meant to encompass the items listed thereafter and equivalents thereof as well as additional items. Unless specified or limited otherwise, the terms “mounted,” “connected,” “supported,” and “coupled” and variations thereof are used broadly and encompass both direct and indirect mountings, connections, supports, and couplings. Further, “connected” and “coupled” are not restricted to physical or mechanical connections or couplings.
Also as used herein, unless otherwise specified or limited, directional terms are presented only with regard to the particular configuration and perspective described. For example, reference to features or directions as “horizontal,” “vertical,” “front,” “rear,” “left,” “right,” and so on are generally made with reference to a particular figure or example and are not necessarily indicative of an absolute orientation or direction. However, relative directional terms for a particular configuration may generally apply to alternative orientations of that configuration. For example, “front” and “rear” directions or features (or “right” and “left” directions or features, and so on) may be generally understood to indicate relatively opposite directions or features.
As used herein in the context of activities or engagement of components, unless otherwise specified or limited, “manual” refers to the use of human hands. In some cases, “manual” engagement or activity can include direct manual engagement or activity: i.e., engagement or activity directly conducted by a user's hands (e.g., a user grasping or manipulating an object by hand). In some cases, “manual” engagement or activity can include engagement or activity via a non-powered hand tool (e.g., pliers).
The following discussion is presented to enable a person skilled in the art to make and use configurations of the present disclosure. Various modifications to the illustrated configurations will be readily apparent to those skilled in the art, and the generic principles herein can be applied to other configurations and applications without departing from configurations of the present disclosure. Thus, configurations of the disclosure are not intended to be limited to configurations shown, but are to be accorded the widest scope consistent with the principles and features disclosed herein. The following detailed description is to be read with reference to the figures, in which like elements in different figures have like reference numerals. The figures, which are not necessarily to scale, depict selected configurations and are not intended to limit the scope of configurations of the disclosure. Skilled artisans will recognize the examples provided herein have many useful alternatives and fall within the scope of configurations of the disclosure
As noted above, in some instances, it may be necessary to transfer fluid, such as blood, from a syringe to a secondary container. In the practice of phlebotomy where a relatively small amount of blood is taken from a patient (e.g., pediatric or elderly phlebotomy), the obtained blood does not pass through a closed transfer system. Instead, donor blood is often extracted via a syringe. The donor blood can then be transferred to a secondary container for testing or transport, such as a microtainer (e.g., BD Microtainer®) or a blood gas syringe. The transfer process from the donor syringe to the secondary container can expose the user (e.g., a healthcare worker) or the immediate environment to the blood via unwanted or unintentional blood spray. Other risks associated with the transfer process can include needle stick, which can increase the chances of blood borne pathogen exposure.
Configurations of the present disclosure can address these and other risks associated with blood transfer. Generally, configurations of the disclosure provide a fluid transfer shield. The fluid transfer shield can be configured as a blood transfer shield and can provide a fluid coupling between a first container and a second container. For example, a first container, such as a syringe (e.g., a donor syringe, a phlebotomy syringe, etc.) having blood contained therein can be coupled to a first port of the transfer shield and a secondary container, such as a microtainer, can be coupled to a second port of the transfer shield to fluidly couple the first container and the secondary container. The fluid transfer shield can allow blood from the first container to be safely deposited into the second container while generally reducing or containing unwanted blood spray.
In the illustrated configuration, the shield 104 defines a generally cylindrical geometry. However, other geometries are possible, such as, for example, flared or conical. In this regard, the base 108 of the shield 104 is generally circular and the shield 104 defines an interior space 114 opposite the exterior 112. The body 102 further includes a first port 116 positioned and generally extending from the exterior 112 of the shield 104 and a second port 118 positioned and generally extending within the interior space 114 of the shield 104.
Also shown in
Opposite the base 108 of the shield 104, the first port 116 extends from a top 120 of the body 102. The first port 116 can be configured as a cylindrical projection with a tapered side wall. In some configurations, the first port 116 can include a Luer lock. In general, Luer locks can provide a standardized system of small-scale fluid fittings for making leak-free or leak-resistant connections between a male-taper fitting and a mating female part. Mating female Luer locks can often be found on medical laboratory instruments, including syringe tips (e.g., hypodermic syringe tips) needles, and stopcocks. In this regard, the first port 116 can include a female Luer lock connector configured to fluidly couple the first port 116 to a first container, such as a donor syringe. However, it should be appreciated that other connection types are possible, including geometries that provide a snap fit, an interference fit, a threaded connection, or other connections configured to provide a leak-free or leak-resistant coupling.
The second port 118 is fluidly coupled to the first port 116 and extends within the interior space 114 of the shield 104 opposite the first port 116. Notably, as further illustrated in
With continued reference to
In use, a secondary container, such as a test tube or microtainer can be secured to the second port 118 to receive fluid, such as blood, from a syringe coupled to the first port 116 via the passageway 128. In particular, the secondary container can be fluidly coupled to the second port 118 so that the second port 118 extends into an opening of the secondary container (i.e., the exterior surface 126 can be inserted into the secondary container). When the second port 118 is fluidly coupled to the secondary container, the second pair of faces 132 can provide a relief path (e.g., an opening, a channel, etc.). The relief path can effectively release air from the secondary container during a fluid transfer process so that the fluid flows smoothly (e.g., without a vacuum or pressure interruption) from a syringe into the secondary container.
With reference to
In general, the fluid transfer shield 100 can define certain geometric ratios that advantageously promote usability and functionality. For example, certain height and width dimensions, particularly height and width ratios, can provide a user with comfortable and intuitive grip position and orientation such that a user may be able to quickly and efficiently couple the fluid transfer shield 100 to a donor syringe and a secondary container. In one example, a height and width ratio of the fluid transfer shield 100 can promote single-handed use, such that a user can actuate a plunger of a donor syringe (e.g., via a thumb) coupled to the fluid transfer shield while simultaneously gripping the fluid transfer shield 100 with the same hand (e.g., index and middle fingers at the first and second flanges 106). In some embodiments, the height and width ratio of the shield 104 may be 1:1 to promote a certain grip, such as, for example, a thumb and a first finger can secure the fluid transfer shield 100 to a first container at the first port 116 and a second finger can help secure a secondary container to the fluid transfer shield at the second port 118.
Other advantageous dimensional ratios of the fluid transfer shield 100 can include the diameter of the base 108 of the shield 104 and the height of the shield 104 in combination with the length that the second port 118 extends into the interior space 114 of the shield 104. These and other ratios, for example, can provide a sufficient shielding zone so that blood or other fluid is transferred into a secondary container without spraying onto or near the user, while the overall fluid transfer shield 100 maintains a size to comfortably fit in and average-sized adult hand. In this regard, a ratio of the height of the shield 104 to the length of the secondary container may be preferably between approximately 1:3 and 1:2 so that about one third to one half of the secondary container is laterally covered by the shield 104 in the axial direction when coupled to the second port 118. However, in other embodiments, such as when a fluid transfer shield similar to the fluid transfer shield 100 is used in the transfer of urine, for example, only 10% of the length of a secondary container may be laterally surrounded by the shield 104 to sufficiently transfer fluid between first and second containers.
In this regard,
The dimensions above refer generally to different heights, widths, and diameters of the fluid transfer shield 100. For example, h1 can correspond to the length that the second port 118 extends into the interior space 114 of the shield 104, h2 can correspond to the length of the passageway 128, h3 can correspond to the overall height of the fluid transfer shield 100, including the shield 104 and the first port 116, d1 can correspond to the diameter of the passageway 128 at a distal end of the first port 116, d2 can correspond to the diameter of the passageway 128 at a distal end of the second port 118, d3 can correspond to the opening diameter of the shield 104 at the base 108, th1 can correspond to the thickness of the body 102 at the top 120 of the fluid transfer shield 100, and w1 can correspond to an over width of the body 102 extending between each of the flanges 106 (i.e., in the longer direction of the oblong footprint). It should be appreciated that additional dimensions of the fluid transfer shield 100 can be interpolated from the dimensions outlined in
h
b
=h
3
−h
2
+h
1
+th
1
Referring now to
In use, the user 144 can grip the shield 104 of the fluid transfer shield 100 at the exterior 112 on either sides of the flanges 106 and support webs 110. The general oblong shape of the fluid transfer shield 100 near the base 108 of the shield 104 provides a grip geometry that can be conducive to securely coupling the syringe 146 and the first port 116. For example, the flanges 106 can provide a point of leverage when the user rotates the fluid transfer shield 100 relative to the syringe.
Like the fluid transfer shield 100, the shield 204 of the fluid transfer shield 200 laterally surrounds the second port 218, which extends into an interior space of the shield opposite the first port 216. The fluid transfer shield 200 can be operated in substantially the same manner as the fluid transfer shield 100, and can be used with first and second containers similarly to those illustrated in
With reference to
Further illustrated in each of
Thus, while the invention has been described above in connection with particular configurations and examples, the invention is not necessarily so limited, and that numerous other embodiments, examples, uses, modifications and departures from the embodiments, examples and uses are intended to be encompassed by the claims attached hereto. The entire disclosure of each patent and publication cited herein is incorporated by reference, as if each such patent or publication were individually incorporated by reference herein.
The present application is based on, claims priority to and incorporates herein by reference in its entirety U.S. Provisional Patent Application No. 63/110,300, filed Nov. 5, 2020, and entitled “Blood Transfer Shield.”
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US2021/058335 | 11/5/2021 | WO |
Number | Date | Country | |
---|---|---|---|
63110300 | Nov 2020 | US |